Smith & Nephew plc (LON:SN) had its price target increased by research analysts at J P Morgan Chase & Co from GBX 1,280 ($16.68) to GBX 1,361 ($17.73) in a research report issued to clients and investors on Monday. The brokerage presently has a “neutral” rating on the stock. J P Morgan Chase & Co’s target price would indicate a potential upside of 2.79% from the company’s current price.
SN has been the topic of several other research reports. Citigroup Inc. reiterated a “sell” rating and issued a GBX 1,160 ($15.11) price target on shares of Smith & Nephew plc in a research note on Monday, July 10th. Berenberg Bank restated a “hold” rating and set a GBX 1,300 ($16.94) price objective on shares of Smith & Nephew plc in a research report on Tuesday, July 18th. Deutsche Bank AG restated a “hold” rating and set a GBX 1,200 ($15.63) price objective on shares of Smith & Nephew plc in a research report on Monday, July 17th. HSBC Holdings plc restated a “hold” rating and set a GBX 1,320 ($17.20) price objective on shares of Smith & Nephew plc in a research report on Wednesday, April 26th. Finally, Jefferies Group LLC restated a “buy” rating and set a GBX 1,350 ($17.59) price objective on shares of Smith & Nephew plc in a research report on Friday, May 5th. One research analyst has rated the stock with a sell rating, eleven have issued a hold rating and two have assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus price target of GBX 1,285.46 ($16.75).
Shares of Smith & Nephew plc (SN) opened at 1330.00 on Monday. The stock’s 50 day moving average price is GBX 1,333.86 and its 200 day moving average price is GBX 1,271.72. Smith & Nephew plc has a one year low of GBX 1,064.91 and a one year high of GBX 1,390.00. The company’s market cap is GBX 11.65 billion.
About Smith & Nephew plc
Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.
Receive News & Ratings for Smith & Nephew plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew plc and related companies with MarketBeat.com's FREE daily email newsletter.
